1. NeuroThera® Efficacy and Safety Trial – 3 (NEST-3): A Double-Blind, Randomized, Sham-Controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Efficacy of Transcranial Laser Therapy with the NeuroThera® Laser System for the Treatment of Acute Ischemic Stroke within 24 h of Stroke Onset. Issue 7 (October 2014) Authors: Zivin, J. A.; Sehra, R.; Shoshoo, A.; Albers, G. W.; Bornstein, N. M.; Dahlof, B.; Kasner, S. E.; Howard, G.; Shuaib, A.; Streeter, J.; Richieri, S. P.; Hacke, W. Journal: International journal of stroke Issue: Volume 9:Issue 7(2014:Oct.) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NeuroThera® Efficacy and Safety Trial – 3 (NEST‐3): a double‐blind, randomized, sham‐controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset. Issue 7 (27th September 2012) Authors: Zivin, J. A.; Sehra, R.; Shoshoo, A.; Albers, G. W.; Bornstein, N. M.; Dahlof, B.; Kasner, S. E.; Howard, G.; Shuaib, A.; Streeter, J.; Richieri, S. P.; Hacke, W.; NEST‐3 investigators Journal: International journal of stroke Issue: Volume 9:Issue 7(2014:Oct.) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗